Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Dubuisson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Antioxidants (Basel, Switzerland)|September 28, 2024
Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending ShieldCamille M Selvais, Maria A Davis-López de Carrizosa, Romain Versele, et al.
Journal of Neurology|March 19, 2018
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cellsBryan Ceronie, Benjamin M Jacobs, David Baker, et al.
Immunology|December 17, 2017
Alemtuzumab depletion failure can occur in multiple sclerosisNicolas Dubuisson, David Baker, Angray S Kang, et al.
Multiple Sclerosis and Related Disorders|October 23, 2017
Validation of an environmentally-friendly and affordable cardboard 9-hole peg testNicolas Dubuisson, Angelika Bauer, Mark Buckley, et al.
Antioxidants (Basel, Switzerland)|January 8, 2025
Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular DystrophyMichel Abou-Samra, Nicolas Dubuisson, Alice Marino, et al.
Frontiers in Immunology|December 26, 2022
Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophyNicolas Dubuisson, María A Davis-López de Carrizosa, Romain Versele, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 13, 2022
AdipoRon enhances healthspan in middle-aged obese mice: striking alleviation of myosteatosis and muscle degenerative markersCamille M Selvais, María A Davis-López de Carrizosa, Maxime Nachit, et al.
Cells|August 26, 2023
The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic MuscleNicolas Dubuisson, Romain Versele, Maria A Davis-López de Carrizosa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 12, 2025
Describing phenotypes in FSHD: an update of the comprehensive clinical evaluation formGiulia Ricci, Francesca Torri, Lucia Ruggiero, et al.
European Journal of Neurology|March 20, 2024
Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measuresBram De Wel, Louise Iterbeke, Lotte Huysmans, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Antioxidants (Basel, Switzerland)|September 28, 2024
Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending ShieldCamille M Selvais, Maria A Davis-López de Carrizosa, Romain Versele, et al.
Journal of Neurology|March 19, 2018
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cellsBryan Ceronie, Benjamin M Jacobs, David Baker, et al.
Immunology|December 17, 2017
Alemtuzumab depletion failure can occur in multiple sclerosisNicolas Dubuisson, David Baker, Angray S Kang, et al.
Multiple Sclerosis and Related Disorders|October 23, 2017
Validation of an environmentally-friendly and affordable cardboard 9-hole peg testNicolas Dubuisson, Angelika Bauer, Mark Buckley, et al.
Antioxidants (Basel, Switzerland)|January 8, 2025
Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular DystrophyMichel Abou-Samra, Nicolas Dubuisson, Alice Marino, et al.
Frontiers in Immunology|December 26, 2022
Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophyNicolas Dubuisson, María A Davis-López de Carrizosa, Romain Versele, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 13, 2022
AdipoRon enhances healthspan in middle-aged obese mice: striking alleviation of myosteatosis and muscle degenerative markersCamille M Selvais, María A Davis-López de Carrizosa, Maxime Nachit, et al.
Cells|August 26, 2023
The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic MuscleNicolas Dubuisson, Romain Versele, Maria A Davis-López de Carrizosa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 12, 2025
Describing phenotypes in FSHD: an update of the comprehensive clinical evaluation formGiulia Ricci, Francesca Torri, Lucia Ruggiero, et al.
European Journal of Neurology|March 20, 2024
Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measuresBram De Wel, Louise Iterbeke, Lotte Huysmans, et al.
Pageof 3